News
VCNX
0.600
NaN%
--
Weekly Report: what happened at VCNX last week (0421-0425)?
Weekly Report · 2d ago
Vaccinex to report new clinical data on pepinemab in enhancing immunotherapy
TipRanks · 04/21 12:55
Vaccinex To Report Promising New Clinical Data Revealing Pepinemab's Unique Mechanism to Enhance Immunotherapy at AACR in Chicago
Benzinga · 04/21 12:47
Weekly Report: what happened at VCNX last week (0414-0418)?
Weekly Report · 04/21 09:33
Vaccinex to Report Promising New Clinical Data Revealing Pepinemab’s Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR)
Barchart · 04/21 07:45
Weekly Report: what happened at VCNX last week (0407-0411)?
Weekly Report · 04/14 09:31
Weekly Report: what happened at VCNX last week (0331-0404)?
Weekly Report · 04/07 09:30
Weekly Report: what happened at VCNX last week (0324-0328)?
Weekly Report · 03/31 09:33
Weekly Report: what happened at VCNX last week (0317-0321)?
Weekly Report · 03/24 09:30
Weekly Report: what happened at VCNX last week (0310-0314)?
Weekly Report · 03/17 09:32
Weekly Report: what happened at VCNX last week (0303-0307)?
Weekly Report · 03/10 09:33
Vaccinex to delist common stock from Nasdaq
TipRanks · 03/07 22:25
Vaccinex plans to delist common stock from Nasdaq
Seeking Alpha · 03/07 22:21
Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market
Barchart · 03/07 16:15
Weekly Report: what happened at VCNX last week (0224-0228)?
Weekly Report · 03/03 09:33
Weekly Report: what happened at VCNX last week (0217-0221)?
Weekly Report · 02/24 09:33
Weekly Report: what happened at VCNX last week (0210-0214)?
Weekly Report · 02/17 09:32
Weekly Report: what happened at VCNX last week (0203-0207)?
Weekly Report · 02/10 09:31
Weekly Report: what happened at VCNX last week (0127-0131)?
Weekly Report · 02/03 09:32
Weekly Report: what happened at VCNX last week (0120-0124)?
Weekly Report · 01/27 09:32
More
Webull provides a variety of real-time VCNX stock news. You can receive the latest news about Vaccinex Inc through multiple platforms. This information may help you make smarter investment decisions.
About VCNX
Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer’s disease, head and neck, pancreatic and breast cancer. Its lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. SEMA4D antibody platform is the application of its knowledge of SEMA4D biology to develop pepinemab for the treatment of various diseases and conditions, including cancer. ActivMAb antibody discovery platform is a human antibody discovery platform based on a method for expressing multipass membrane proteins, as well as large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of mammalian pox viruses.